Projects per year
Personal profile
Area of Expertise
Dr. Basha's research expertise is in the field of experimental therapeutics and cancer. His research focuses on examining aberrant expression of molecular markers associated with aggressive disease and poor prognosis for a variety of human malignancies.
Ongoing research focuses on testing the combination of novel investigational agents with other standard therapeutic options (chemotherapy and/or radiation), and understanding the potential molecular pathways associated with proposed combinations. Novel therapeutic strategies involving small molecules, herbal products, and their analogs are under testing through rigorous pre-clinical screening using models for leukemia, pancreatic, ovarian, prostate, and central nervous system cancers.
Ongoing research focuses on testing the combination of novel investigational agents with other standard therapeutic options (chemotherapy and/or radiation), and understanding the potential molecular pathways associated with proposed combinations. Novel therapeutic strategies involving small molecules, herbal products, and their analogs are under testing through rigorous pre-clinical screening using models for leukemia, pancreatic, ovarian, prostate, and central nervous system cancers.
Education/Academic qualification
PhD in Neurobiology, Sri Venkateswara University
MS in Molecular Physiology, Sri Venkateswara University
BS in Biology and Chemistry, Sri Venkateswara University
Fingerprint Dive into the research topics where Riyaz Basha is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Neoplasms
Medicine & Life Sciences
Sp Transcription Factors
Medicine & Life Sciences
Pancreatic Neoplasms
Medicine & Life Sciences
Alzheimer Disease
Medicine & Life Sciences
Sp1 Transcription Factor
Medicine & Life Sciences
Amyloid beta-Protein Precursor
Medicine & Life Sciences
Growth
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2013 2022
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Cancer Research
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Cancer Research
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
Texas Center of Minority Health, Education, Research and Outreach - Admin/Development Core
Vishwanatha, J., Jones, H., He, J., Basha, R. & Nandy, K.
NIMHD: Natl Institute on Minority Health
23/09/17 → 31/05/22
Project: Research
Research Output 1996 2019
1
Citation
(Scopus)
An institutional coordinated plan for effective partnership s to achieve health equity and biomedical workforce diversity
Vishwanatha, J. K., Basha, R., Nair, M. & Jones, H. P., Feb 2019, In : Ethnicity and Disease. 29, p. 129-134 6 p.Research output: Contribution to journal › Article
Open Access
Health
Aptitude
Translational Medical Research
Organized Financing
Self Efficacy
1
Citation
(Scopus)
Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells
Shelake, S., Sankpal, U. T., Eslin, D., Bowman, P., Simecka, J., Raut, S. L., Ray, A. & Basha, R. M., 15 Feb 2019, In : Apoptosis. 24, 1-2, p. 21-32 12 p.Research output: Contribution to journal › Article
Ewing's Sarcoma
Vincristine
Cells
Caspase 7
Cell Survival
Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells
Patil, S., Sankpal, U. T., Hurtado, M., Bowman, W. P., Murray, J., Borgmann, K., Ghorpade, A., Sutphin, R., Eslin, D. & Basha, R., 15 Jul 2019, In : Gene. 705, p. 67-76 10 p.Research output: Contribution to journal › Article
Medulloblastoma
Vincristine
tolfenamic acid
Cell Cycle
Apoptosis
2
Citations
(Scopus)
Copper-tolfenamic acid: evaluation of stability and anti-cancer activity
Hurtado, M., Sankpal, U. T., Chhabra, J., Brown, D. T., Maram, R., Patel, R., Gurung, R. K., Simecka, J., Holder, A. A. & Basha, R. M., 15 Feb 2019, In : Investigational New Drugs. 37, 1, p. 27-34 8 p.Research output: Contribution to journal › Article
Copper
Neoplasms
Powders
tolfenamic acid
Cell Line
Diversity in the era of precision medicine - From bench to bedside implementation
Mamun, A., Nsiah, N. Y., Srinivasan, M., Chaturvedula, A., Basha, R., Cross, D., Jones, H. P., Nandy, K. & Vishwanatha, J. K., 1 Jan 2019, In : Ethnicity and Disease. 29, 3, p. 517-524 8 p.Research output: Contribution to journal › Article
Precision Medicine
Health
Pharmacogenetics
Genomics
Population